Preconception Wellness Line: Underclaim by Design, Document Everything

Preconception buyers read everything and drop a brand on one overclaim. This playbook builds the line that survives that read: a gentle topical plus a 30-day oral course, documented end to end.

01 · The problem

Fertility-journey buyers read every ingredient and drop brands on a single overclaim. The shelf answers with either clinic products (wrong register for daily life) or gentle claims with no documentation. A documented, deliberately underclaimed daily pairing — gentle topical care plus a mild oral course — is the credible middle.

02 · Scientific rationale

The formula set is minimal by design: a rose-EV topical mist plus a 30-day OralBio oral liquid. No hormone-adjacent storytelling, no actives that need a claim to sell. Documentation is the marketing: batch COAs, characterization baseline, and the material line's DMF/INCI chain, shared openly with buyers who will read all of it.

03 · Program documentation

Protocol documentation for this program family is maintained in TONGNIAN's internal files — network-clinic protocol series and anonymized case records where applicable [5]. Partner access under NDA; the evidence hierarchy stays explicit — published reviews first, internal observational programs second, case documentation third. [6]

Method anchors: [1] EV biology and cargo [2] MISEV2018 characterization [3] category evidence (review or registered study) [4] formulation and handling guidance [5] national measurement guideline (2026 No. 17) [6] internal protocol and case documentation.

04 · Product architecture

05 · Process & QC

EV material runs on the fully enclosed 0.5–5 L micro-batch line — closed-tubing culture, scheduled harvest, tangential-flow separation and concentration, sterile filtration — with low-shear handling qualified at process validation [4]. QC panel design follows MISEV2018 [2] and the national measurement guideline (2026 No. 17, TONGNIAN a drafting organization) [3].

Fig. 1 — The pairing map: gentle topical + mild oral, one course card.

06 · Regulatory pathway: EU & US first

US: the oral course sits within the dietary-supplement framework with the standard discipline; EU: food-supplement route with permitted-claims lists only. Topical mist: cosmetic track. No fertility, hormonal, or clinical claims of any kind — The program underclaims by design — that restraint is the market position.

07 · Expected outcomes

• Underclaiming is the position: this buyer trusts the brand that says less and shows the COA chain.
• Full documentation transparency: the COA chain shared openly — the diligence pass is the conversion.
• Clinic-adjacent channel: fits alongside fertility-clinic wellness recommendations without conflict.

No claims are made beyond the cosmetic, supplement, or professional-use framing of the destination market — authority comes from documentation and batch measurement.

08 · Commercial framework

Sample kits in 3–5 days; pilot from 500 units; production from 2,000 units; standard lead 15 workdays — all indicative, quoted per request. White-label and program naming run through the OBM program.

Request a quote · Line fact-sheet

References

1. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.
2. Ávila-Gálvez MÁ, et al. Oral delivery of ellagic acid encapsulated in milk exosomes. Mol Nutr Food Res. 2026.
3. Guideline for Exosome Particle Size and Concentration Measurement (2026 No. 17), national standard — TONGNIAN, drafting organization.
4. TONGNIAN network clinics. Anonymized internal protocol and case documentation (partner access under NDA).